Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Clinical trial NCT01059526 · COMPLETED

Trial details

NCT number: NCT01059526
Sponsor: Shire
Status: COMPLETED
Study type: OBSERVATIONAL

Hereditary Angioedema (HAE)

Start date: 2010-02-01
Primary completion: 2013-09-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.